Browsing Tag
Johnson & Johnson
102 posts
Jury awards $45m in damages in asbestos-related lawsuit against Johnson & Johnson
In a landmark decision, the Circuit Court of Cook County in Chicago has found Johnson & Johnson (NYSE:…
Johnson & Johnson announces $13.1bn acquisition of Shockwave Medical to strengthen medtech division
In a monumental move within the medical technology sector, Johnson & Johnson (NYSE: JNJ) has announced its acquisition…
Nanobiotix achieves milestone in cancer treatment with NBTXR3, secures $20m from Janssen
NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX), a leader in the field of biotechnology, announced a significant achievement in…
Bausch + Lomb acquires Johnson & Johnson Vision’s Blink product line
Bausch + Lomb, an esteemed global eye health company, has broadened its portfolio by purchasing Johnson & Johnson…
Marksans Pharma gets FDA final approval for Famotidine Tablets
Marksans Pharma said that it has been granted final approval for the over-the-counter (OTC) use of Famotidine Tablets…
Johnson & Johnson completes $17bn acquisition of Abiomed
Johnson & Johnson (J&J) has closed the previously announced acquisition of Abiomed, a medical device technology company, for…
Johnson & Johnson to purchase heart pump maker Abiomed for $16.6bn
Johnson & Johnson (J&J) has agreed to acquire Abiomed, a NASDAQ-listed cardiovascular medical technology provider, in an all-cash…
FDA approves Janssen’s TECVAYLI for multiple myeloma treatment
The Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson, announced the US Food and Drug Administration’s approval…
Granules India gets FDA approval for Loperamide Hydrochloride and Simethicone Tablets
Granules India has secured approval for its abbreviated new drug application (ANDA) for Loperamide Hydrochloride and Simethicone Tablets,…
Healthcare giant Johnson & Johnson to spin off consumer health business
Johnson & Johnson (JNJ) has announced plans to carve out its consumer health business into a new publicly…